Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots ...

Edoxaban, an oral anticoagulant, was equally or more effective than warfarin in reducing the risk of stroke and blood clots for patients after heart valve replacement surgery, according to preliminary ...

The following is a summary of "Tenecteplase versus alteplase for acute stroke within 4·5 h of onset (ATTEST-2): a randomised, ...

Low event rates and short TTRs with warfarin were notable, and questions persist as to which patients truly need OAC.

Scott Kellen; Chief Financial Officer, Company Secretary; DiaMedica Therapeutics Inc Matthew Caufield; Analyst; H.C. Wainright.